WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 |
PATENTSCOPE
Search International and National Patent Collections
World Intellectual Property Organization
Search
Browse
Translate
Options
News
Login
Help
1. (WO2005000299) COMPOSITIONS COMPRISING BALAGLITAZONE AND FURTHER ANTIDIABETIC COMPOUNDS
PCT Biblio. Data
Description
Claims
National Phase
Notices
Drawings
Documents
Latest bibliographic data on file with the International Bureau   
Pub. No.:    WO/2005/000299    International Application No.:    PCT/DK2004/000448
Publication Date: 06.01.2005 International Filing Date: 24.06.2004
IPC:
A61K 31/216 (2006.01), A61K 31/427 (2006.01), A61K 31/64 (2006.01), A61K 45/06 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
21
Esters, e.g. nitroglycerine, selenocyanates
215
of carboxylic acids
216
of acids having aromatic rings, e.g. benactizyne, clofibrate
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
425
Thiazoles
427
not condensed and containing further heterocyclic rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
64
Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Applicants: DR. REDDY'S RESEARCH FOUNDATION; 7-1-27, Ameerpet, Hyderabad-500016 (IN) (For All Designated States Except US).
WASSERMANN, Karsten [DK/US]; (US) (For US Only).
WULFF, Erik, Max [DK/DK]; (DK) (For US Only)
Inventors: WASSERMANN, Karsten; (US).
WULFF, Erik, Max; (DK)
Common
Representative: 		NOVO NORDISK A/S; Corporate Patents, Novo Allé, DK-2880 Bagsværd (DK)
Priority Data:
60/483,196 27.06.2003 US
PA 2003 00973 27.06.2003 DK
Title (EN) COMPOSITIONS COMPRISING BALAGLITAZONE AND FURTHER ANTIDIABETIC COMPOUNDS
(FR) COMPOSITIONS COMPRENANT DE LA BALAGLITAZONE ET D'AUTRES COMPOSES ANTIDIABETIQUES
Abstract: front page image
(EN)Methods for the treatment of type 2 diabetes and related conditions comprising the admini-stration of balaglitazone in combination with one or more other antidiabetic compound is pro-vided together with combinations useful in said treatment.
(FR)L'invention concerne des méthodes destinées à traiter le diabète de type 2 et des affections associées et consistant à administrer de la balaglitazone en combinaison avec un ou plusieurs autres composés antidiabétiques. L'invention concerne également des combinaisons utiles dans ce traitement.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Org. (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (EAPO) (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)